Curafosfamide-1000 (Irinotecan Vials) 1000mg

Curafosfamide-1000 (Irinotecan) 1000mg vials are used for cancer treatment. This chemotherapy medication helps manage solid tumors with precise dosing. Store at ambient temperature and handle with care. Always consult a healthcare provider before use.

Strength

1000mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Mediclone Health Care Pvt Ld

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Irinotecan 1000mg vials are prescribed to treat various solid tumors, including colorectal cancer. It is often used when other treatments are ineffective. Patients may wonder, 'what is irinotecan used for?'—this medication targets rapidly dividing cancer cells. It is typically administered in clinical settings under professional supervision.

Side Effects

Irinotecan may cause temporary side effects such as nausea, fatigue, or hair thinning. Some patients experience digestive discomfort or changes in blood cell counts. These effects vary by individual and are monitored during treatment. Hydration and rest can help manage these responses.

Precautions & Warnings

Store irinotecan vials at room temperature away from moisture and direct light. Keep out of reach of children and pets. Avoid handling if pregnant or breastfeeding. Use protective gloves when preparing doses to prevent skin contact. Dispose of unused medication properly.

Avoid Interactions

Irinotecan may interact with other chemotherapy drugs, blood thinners, or medications affecting liver enzymes. Alcohol and certain supplements can amplify side effects. Always disclose all medications to your healthcare provider. CYP3A4 inhibitors or inducers may alter irinotecan’s effectiveness.

Frequently Asked Questions

Irinotecan is primarily used to treat solid tumors like colorectal cancer. It is prescribed when other treatments are not effective.

Irinotecan is given as an intravenous infusion in a clinical setting. Dosage and schedule depend on individual treatment plans.

Common side effects include nausea, fatigue, and hair thinning. Digestive discomfort and blood count changes may also occur.

Irinotecan requires a prescription and is typically dispensed through licensed pharmacies or healthcare providers.

Store irinotecan vials at room temperature, away from moisture and direct light. Keep out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.